x
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
For
the quarterly period ended June 30, 2008.
|
|
or
|
|
¨
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
For
the transition period
from to
.
|
Delaware
|
20-3200738
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer
|
Incorporation
or Organization)
|
Identification
No.)
|
Large
Accelerated Filer ¨
|
Accelerated
Filer ¨
|
Non-Accelerated
Filer ¨ (Do
not check if a smaller reporting company)
|
Smaller
Reporting Company x
|
PART
I — FINANCIAL INFORMATION
|
|
1
|
||
ITEM
1
|
—
FINANCIAL STATEMENTS (UNAUDITED)
|
|
1
|
|
|
Balance
Sheets
|
|
1
|
|
|
As
of June 30, 2008 and December 31, 2007
|
|
1
|
|
|
Statements
of Income
|
|
2
|
|
|
Statement
of Stockholders Equity (deficit)
|
|
3
|
|
|
Statements
of Cash Flows
|
|
4
|
|
|
Notes
to Financial Statements
|
|
5
|
|
ITEM
2
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
|
13
|
|
ITEM
3
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
16
|
|
ITEM
4
|
CONTROLS
AND PROCEDURES
|
|
16
|
|
ITEM
4T
|
CONTROLS
AND PROCEDURES
|
|
16
|
|
|
|
|
||
PART
II — OTHER INFORMATION
|
|
17
|
||
ITEM
1
|
LEGAL
PROCEEDINGS
|
|
17
|
|
ITEM
1A
|
RISK
FACTORS
|
|
17
|
|
ITEM
2
|
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
|
17
|
|
ITEM
3
|
DEFAULTS
UPON SENIOR SECURITIES
|
|
17
|
|
ITEM
4
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
|
17
|
|
ITEM
5
|
OTHER
INFORMATION
|
|
18
|
|
ITEM
6
|
EXHIBITS
|
|
18
|
|
|
|
|
||
SIGNATURES
|
|
19
|
June 30, 2008
|
December 31, 2007
|
||||||
(Unaudited)
|
(Audited)
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
|
$
|
374,675
|
$
|
569,723
|
|||
Investment
in trust account
|
58,489,506
|
58,309,161
|
|||||
Prepaid
Expenses
|
39,334
|
94,444
|
|||||
Total
current assets
|
58,903,515
|
58,973,328
|
|||||
Deferred
Acquisition Cost
|
176,644
|
-
|
|||||
Total
assets
|
$
|
59,080,159
|
$
|
58,973,328
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Deferred
underwriting fees
|
$
|
2,340,000
|
$
|
2,340,000
|
|||
Accounts
payable and accrued expenses
|
75,406
|
79,024
|
|||||
Accrued
interest on notes payable, stockholders
|
22,312
|
9,481
|
|||||
Income
taxes payable
|
64,762
|
85,000
|
|||||
Due
to stockholders
|
8,820
|
8,820
|
|||||
Notes
payable, stockholders
|
105,000
|
205,000
|
|||||
Total
current liabilities
|
2,616,300
|
2,727,325
|
|||||
Common
Stock, subject to possible redemption, 1,462,499 shares
|
11,290,492
|
11,144,242
|
|||||
Commitments
and Contingencies
|
|||||||
STOCKHOLDERS’
EQUITY
|
|||||||
Preferred
stock, $0.001 par value
|
|||||||
Authorized
1,000,000 shares; none issued
|
–
|
–
|
|||||
Common
stock, $0.001 par value
|
|||||||
Authorized
50,000,000 shares
|
|||||||
Issued
and outstanding 1,875,000 shares and 9,375,000 at December 31, 2006
and
June 30, 2007
|
9,375
|
9,375
|
|||||
Additional
paid-in-capital
|
44,293,484
|
44,439,734
|
|||||
Earnings
accumulated during the development stage
|
870,508
|
652,652
|
|||||
Total
stockholders’ equity
|
45,173,367
|
45,101,761
|
|||||
Total
liabilities and stockholders’ equity
|
$
|
59,080,159
|
$
|
58,973,328
|
Six Months Ended June 30,
|
Three Months Ended June 30,
|
For the period from
July 19, 2005
(inception) to
|
||||||||||||||
|
2008
|
2007
|
2008
|
2007
|
June 30, 2008
|
|||||||||||
Interest
Income
|
$
|
612,584
|
$
|
342,434
|
$
|
248,846
|
$
|
342,434
|
$
|
1,959,506
|
||||||
Operating
expenses
|
412,135
|
124,275
|
156,452
|
100,169
|
991,825
|
|||||||||||
Income
before interest expense and income taxes
|
200,449
|
218,159
|
92,394
|
242,265
|
967,681
|
|||||||||||
Interest
expense-related party
|
2,831
|
11,079
|
1,061
|
8,243
|
31,049
|
|||||||||||
Income
before provision for income taxes
|
197,618
|
207,080
|
91,333
|
234,022
|
936,632
|
|||||||||||
Provision
for income taxes
|
(20,238
|
)
|
30,400
|
84,497
|
30,400
|
66,124
|
||||||||||
Net
income for the period
|
$
|
217,856
|
$
|
176,680
|
$
|
6,836
|
$
|
203,622
|
$
|
870,508
|
||||||
Weighted
average shares outstanding -
|
|
|
|
|
|
|||||||||||
Basic
|
9,375,000
|
4,381,250
|
9,375,000
|
6,887,500
|
4,849,582
|
|||||||||||
Diluted
|
11,871,317
|
5,315,901
|
11,880,099
|
8,746,532
|
10,357,506
|
|||||||||||
Net
income per share - Basic
|
$
|
0.02
|
$
|
0.04
|
$
|
—
|
$
|
0.03
|
$
|
0.18
|
||||||
Net
income per share - Diluted
|
$
|
0.02
|
$
|
0.03
|
$
|
—
|
$
|
0.02
|
$
|
0.08
|
Common Stock
|
Additional
|
Deficiency
Accumulated
During the
Development
|
Total
Stockholders’
Equity
|
|||||||||||||
Shares
|
Amount
|
Paid-in capital
|
Stage
|
(Deficit)
|
||||||||||||
Common
shares issued
|
|
|
|
|
|
|||||||||||
July
19, 2005 at (inception) at $0.0133
|
1,875,000
|
$
|
1,875
|
$
|
23,125
|
$
|
–
|
$
|
25,000
|
|||||||
Net
loss for the period
|
–
|
–
|
–
|
(67,116
|
)
|
(67,116
|
)
|
|||||||||
Balances
at December 31, 2005
|
1,875,000
|
$
|
1,875
|
$
|
23,125
|
$
|
(67,116
|
)
|
$
|
(42,116
|
)
|
|||||
Net
loss for the period
|
–
|
–
|
–
|
(77,534
|
)
|
(77,534
|
)
|
|||||||||
Balances
at December 31, 2006
|
1,875,000
|
1,875
|
23,125
|
(144,650
|
)
|
(119,650
|
)
|
|||||||||
Proceeds
of private placement- April 25, 2007
|
187,500
|
187
|
1,499,813
|
–
|
1,500,000
|
|||||||||||
Common
shares issued June 30, 2007 @$8 per share
|
7,312,500
|
7,313
|
58,492,687
|
–
|
58,500,000
|
|||||||||||
Expenses
of the Offering
|
–
|
–
|
(4,431,649
|
)
|
–
|
(4,431,649
|
)
|
|||||||||
Proceeds
subject to possible redemption of 1,462,499 shares
|
–
|
–
|
(11,144,242
|
)
|
–
|
(11,144,242
|
)
|
|||||||||
Net
income for the period
|
–
|
–
|
–
|
797,302
|
797,302
|
|||||||||||
Balances
at December 31, 2007
|
9,375,000
|
9,375
|
44,439,734
|
652,652
|
45,101,761
|
|||||||||||
Adjustment
to value of shares subject to possible redemption
|
|
|
(146,250
|
)
|
|
(146,250
|
)
|
|||||||||
Net
income for the period
|
|
|
|
217,856
|
217,856
|
|||||||||||
Balances
at June 30, 2008
|
9,375,000
|
$
|
9,375
|
$
|
44,293,484
|
$
|
870,508
|
$
|
45,173,367
|
Six Months Ended June 30,
|
For the Period From July 19, 2005
(Inception) to
|
|||||||||
2008
|
2007
|
June
30, 2008
|
||||||||
Cash
flows from operating activities
|
||||||||||
Net
income
|
$
|
217,856
|
$
|
176,680
|
$
|
870,508
|
||||
Adjustments
to reconcile net income to net cash provided by operating
activities
|
||||||||||
Deferred
Acquisition Cost
|
(176,644
|
)
|
–
|
(176,644
|
)
|
|||||
Prepaid
Expenses
|
55,110
|
(151,111
|
)
|
(39,334
|
)
|
|||||
Accounts
payable and accrued expenses
|
(3,618
|
)
|
(66,128
|
)
|
75,406
|
|||||
Income
tax payable
|
(20,238
|
)
|
30,400
|
64,762
|
||||||
Accrued
interest on notes payable, stockholders
|
12,831
|
10,079
|
22,312
|
|||||||
Net
cash provided by (used in) operating activities
|
85,297
|
(80
|
)
|
817,010
|
||||||
Cash
flows from investing activities:
|
||||||||||
Payment
to trust account
|
(180,345
|
)
|
(58,213,919
|
)
|
(58,489,506
|
)
|
||||
Net
cash used in investing activities
|
(180,345
|
)
|
(58,213,919
|
)
|
(58,489,506
|
)
|
||||
Cash
flows from financing activities
|
||||||||||
Proceeds
from advances from stockholder
|
–
|
–
|
8,820
|
|||||||
Proceeds
from sale of shares of common stock
|
–
|
–
|
25,000
|
|||||||
Proceeds
from notes payable, stockholders
|
–
|
–
|
348,791
|
|||||||
Repayment
of notes payable, stockholders
|
(100,000
|
)
|
–
|
(243,791
|
)
|
|||||
Proceeds
from private placement
|
–
|
1,500,000
|
1,500,000
|
|||||||
Proceeds
from initial public offering
|
–
|
58,500,000
|
58,500,000
|
|||||||
Payment
of expenses of offering
|
–
|
(1,646,978
|
)
|
(2,091,649
|
)
|
|||||
Net
cash provided by financing activities
|
(100,000
|
)
|
58,353,022
|
58,047,171
|
||||||
Net
increase (decrease) in cash
|
(195,048
|
)
|
139,023
|
374,675
|
||||||
Cash,
beginning of period
|
569,723
|
24,279
|
–
|
|||||||
Cash,
end of period
|
$
|
374,675
|
$
|
163,302
|
$
|
374,675
|
||||
Supplemental
disclosure of cash flow information
|
||||||||||
Cash
paid for interest
|
$
|
–
|
$
|
–
|
8,734
|
|||||
Supplemental
schedule of non-cash financing activities:
|
||||||||||
Accrual
of deferred underwriting costs
|
$
|
–
|
$
|
2,352,333
|
$
|
2,340,000
|
1. Organization,
Proposed Business Operations
|
Basis
of Presentation
|
|
and
Summary of Significant Accounting Policies
|
The
financial statements of Vector Intersect Security Acquisition Corporation
(the ‘‘Company’’) , for the six months ended June 30, 2008 and 2007, for
the three months ended June 30, 2008 and 2007 and for the period
from July
19, 2005 (inception) to June 30, 2008, are unaudited. In the opinion
of
management, all adjustments (consisting of normal adjustments) have
been
made that are necessary to present fairly the financial position
of the
Company as of June 30, 2008 and the results of its operations and
its cash
flows for the six months ended June 30, 2008 and 2007, the three
months
ended June 30, 2008 and 2007 and for the period from July 19, 2005
(inception) to June 30, 2008. Operating results for the interim periods
presented are not necessarily indicative of the results to be expected
for
the full fiscal year. The balance sheet as of December 31, 2007 has
been
derived from the audited financial statements.
|
|
Vector
Intersect Security Acquisition Corporation (the ‘‘Company’’) was
incorporated in Delaware on July 19, 2005 as a blank check company.
It’s
objective is to acquire, through a merger, capital stock exchange,
asset
acquisition or other similar business combination (as defined below),
one
or more businesses in the homeland security, national security and/or
command and control industries.
|
||
The
registration statement for the Company’s initial public offering (the
‘‘Public Offering’’) was declared effective on April 25, 2007. The Company
completed a private placement (the ‘‘Private Placement’’) and received
gross proceeds of $1,500,000 on April 25, 2007. The Company consummated
the Public Offering on May 1, 2007 and received gross proceeds of
$58,500,000. The Company’s management has broad discretion with respect to
the specific application of the net proceeds of the Private Placement
and
the Public Offering (collectively the (‘‘Offerings’’) each as described in
Note 2), although substantially all of the net proceeds of the Offerings
are intended to be generally applied toward consummating a business
combination with a target company. As used herein, a ‘‘target business’’
shall include an operating business in the homeland security or defense
industries, or a combination thereof, and a ‘‘business combination’’ shall
mean the acquisition by the Company of such a target business. There
is no
assurance that the Company will be able to effect a business combination
successfully.
|
Of
the proceeds of the Offerings, $58,030,000 was placed in a trust
account
(‘‘Trust Account’’) at JP MorganChase, New York City, New York, maintained
by American Stock Transfer & Trust Company, the Company’s transfer
agent. This amount includes the net proceeds of the Public Offering
and
the Private Placement, and $2,340,000 of deferred underwriting
compensation fees (the ‘‘Discount’’) which will be paid to Rodman &
Renshaw, LLC if, and only if, a business combination is consummated.
The
funds in the Trust Account will be invested until the earlier of
(i) the
consummation of the Company’s first business combination or (ii) the
liquidation of the Trust Account as part of a plan of dissolution
and
liquidation approved by our stockholders. Up to $1,500,000 of interest
income on the Trust Account may be used to fund the Company’s working
capital requirements including payments for legal and accounting
fees to
due diligence on prospective acquisitions and continuing general
and
administrative expenses.
|
||
After
signing a definitive agreement for the acquisition of a target business,
the Company will submit such transaction for stockholder approval.
In the
event (i) the Business Combination is not approved by a majority of
the shares of common stock issued in our initial public offering
or (ii)
20% or more of the shares of common stock held by the public stockholders
vote against the Business Combination and exercise their conversion
rights
described below, the Business Combination will not be
consummated.
|
||
With
respect to the first Business Combination which is approved and
consummated, any Public Stockholder who voted against the Business
Combination may demand that the Company redeem its, his or her shares.
The
per share redemption price will equal the amount in the Trust Fund,
plus
interest (net of taxes payable and net of up to $1,500,000 of interest
income on the Trust Fund that may be used to fund the Company’s working
capital) calculated as of two business days prior to the proposed
Business
Combination, divided by the number of shares of common stock held
by
Public Stockholders at the consummation of the Public Offering.
Accordingly, Public Stockholders holding approximately 19.99% of
the
aggregate number of shares owned by all Public Stockholders may seek
redemption of their shares in the event of a Business Combination.
Such
Public Stockholders are entitled to receive their per share interest
in
the Trust Fund computed without regard to the shares held by the
Initial
Stockholders.
|
||
Use
of estimates
|
||
The
preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period.
Actual
results could differ from those estimates.
|
Concentration
of Credit Risk
|
||
Financial
instruments that potentially subject the Company to credit risk consist
of
cash and cash equivalents. The Company’s policy is to limit the amount of
credit exposure to any one financial institution and place investments
with financial institutions or in short-term money market funds that
provide minimal exposure to interest rate and credit
risk.
|
||
Earnings
per Common Share
|
||
Basic
earnings per share (‘‘EPS’’) is computed by dividing net income applicable
to common stock by the weighted average common shares outstanding
during
the period. Diluted EPS reflects the additional dilution for all
potentially dilutive securities such as stock warrants.
|
||
Recent
Accounting Pronouncements
|
||
Management
does not believe that any recently issued, but not yet effective,
accounting standards if currently adopted would have a material affect
on
the accompanying financial statements.
|
||
2. Offerings
|
On
April 25, 2007 the Company sold 187,500 units in a Private Placement,
and
on May 1, 2007 the Company sold 7,312,500 units in the Public Offering
(collectively the ‘‘Units’’). Each Unit consists of one share of the
Company’s common stock, $0.001 par value, and one common stock purchase
warrant (‘‘Warrants’’). Each Warrant entitles the holder to purchase from
the Company one share of common stock at an exercise price of $5.00
per
share (which Warrant may be exercised on a cashless basis) commencing
the
later of (a) one year from the effective date of the Public Offering;
or
(b) the completion of a Business Combination with a target business
and
expiring four years from the date of the Public Offering prospectus
(unless earlier redeemed). The Warrant is redeemable at a price of
$0.01
per Warrant upon 30 days notice after the Warrant becomes exercisable,
only in the event that (a) the last sales price of the common stock
is at
least $11.50 per share for any 20 trading days within a 30-trading-day
period ending on the third business day prior to date on which notice
of
redemption is given.
|
|
The
Company will use its best efforts to cause a registration statement
to
become effective on or prior to the commencement of the Warrant exercise
period and to maintain the effectiveness of such registration statement
until the expiration of the Warrants. The Warrants may not be exercised
in
the absence of an effective registration statement and, in the event
that
the Company is unable to maintain the effectiveness of such registration
statement until the expiration of the Warrants, and therefore is
unable to
deliver registered shares, the Warrants may expire unexercised and
worthless. In no event will the Company be required to net-cash settle
the
Warrants. Accordingly, the Company has determined that the Warrants
should
be classified in stockholders’ equity upon issuance in accordance with the
guidance in EITF 00-19, ‘‘Accounting for Derivative Financial Instruments
Indexed to, and Potentially Settled in, a Company’s Own
Stock’’.
|
3. Deferred
Acquisition Costs
|
Deferred
acquisition costs consist of legal, auditing, regulatory filing,
underwriting fees and other costs incurred related to the Proposed
Acquisition.
|
|
4. Advances
from Stockholder
|
In
March 2006 and in September 2006, a stockholder advanced the Company
a
total of $8,820 for operating expenses. The advance is non-interest
bearing and is due on demand.
|
|
5. Notes
Payable, Stockholders
|
In
addition to their purchase of the Company’s common stock, two of the
Company’s stockholders and officers advanced the Company an aggregate of
$205,000 in exchange for unsecured promissory notes. The notes bear
interest at a rate of 4% per annum with principal and accrued interest
due
no later than the first anniversary of the Public Offering. During
the
quarter ended March 31, 2008, the Company repaid $100,000 of these
loans.
|
|
The
Company issued two additional notes with an aggregate principal amount
of
$143,791 to SCP Private Equity Management Company, LLC. The notes
bore
interest at a rate of 5.5% per annum with principal and were repaid
during
the fiscal year of 2007.
|
||
6. Per
Share Information
|
In
accordance with SFAS No. 128, ‘‘Earnings Per Share,’’ basic income per
common share (‘‘Basic EPS’’) is computed by dividing the net income by the
weighted-average number of shares outstanding. Diluted income per
common
share (‘‘Diluted EPS’’) is computed by dividing the net income by the
weighted-average number of common shares and dilutive common share
equivalents then outstanding. SFAS No. 128 requires the presentation
of
both Basic EPS and Diluted EPS on the face of the Company’s Condensed
Statements of Income.
|
|
The
following table sets forth the computation of basic and diluted per
share
information:
|
Three Months Ended
|
Six Months Ended
|
For the period
from
July 19, 2005
(inception) to
|
||||||||||||||
June 30, 2008
|
June 30, 2007
|
June 30, 2008
|
June 30, 2007
|
June 30, 2008
|
||||||||||||
Interest
Income
|
$
|
612,584
|
$
|
342,434
|
$
|
248,846
|
$
|
342,434
|
$
|
1,959,506
|
||||||
Operating
expenses
|
412,135
|
124,275
|
156,452
|
100,169
|
991,825
|
|||||||||||
Income
before interest expense and income taxes
|
200,449
|
218,159
|
92,394
|
242,265
|
967,681
|
|||||||||||
Interest
expense – related party
|
2,831
|
11,079
|
1,061
|
8,243
|
31,049
|
|||||||||||
Income
before provision for income taxes
|
197,618
|
207,080
|
91,333
|
234,022
|
936,632
|
|||||||||||
Provision
for income taxes
|
(20,238
|
)
|
30,400
|
84,497
|
30,400
|
66,124
|
||||||||||
Net
income for the period
|
$
|
217,856
|
$
|
176,680
|
$
|
6,836
|
$
|
203,622
|
$
|
870,508
|
||||||
Weighted
average shares outstanding –
|
||||||||||||||||
basic
|
9,375,000
|
4,381,250
|
9,375,000
|
6,887,500
|
4,849,582
|
|||||||||||
diluted
|
11,871,317
|
5,315,901
|
11,880,099
|
8,746,532
|
10,357,506
|
|||||||||||
Net
income per share – Basic
|
$
|
0.02
|
$
|
0.04
|
$
|
—
|
$
|
0.03
|
$
|
0.18
|
||||||
Net
income per share – Diluted
|
$
|
0.02
|
$
|
0.03
|
$
|
—
|
$
|
0.02
|
$
|
0.08
|
7.
Commitments
|
In
connection with the Public Offering the Company sold to the representative
of the underwriter for $100 an option to purchase up to a total of
731,250
Units. The Units issuable upon exercise of this option are identical
to
those offered to the public, except that the Warrants underlying
this
option are exercisable at $5.50 (110% of the exercise price of the
Warrants included in the units sold in the Public Offering). This
option
is exercisable at $8.80 per unit commencing on the later of the
consummation of a Business Combination and one year from the date
of
offerings and expiring five years from the date of offerings. The
option
and the 731,250 units, the 731,250 shares of common stock and the
731,250
Warrants underlying such units, and the 731,250 shares of common
stock
underlying such Warrants, have been deemed compensation by the National
Association of Securities Dealers (‘‘NASD’’) and are therefore subject to
a 180-day lock-up pursuant to Rule 2710(g)(1) of the NASD Conduct
Rules.
Additionally, the option may not be sold, transferred, assigned,
pledged
or hypothecated for a one-year period (including the foregoing 180-day
period) following the date of offerings. However, the option may
be
transferred to any underwriter and selected dealers participating
in the
offering and their bona fide officers or
partners.
|
The Company accounted for this purchase option as a cost of raising capital and will include the instrument as equity in the financial statements. Accordingly, there will be no net impact on the Company’s financial position or results of operations, except for the recording of the $100 proceeds from the sale. The Company estimated, based upon a Black-Scholes model, that the fair value of the purchase option on the date of sale is approximately $3.40 per unit (or $2,486,250 in the aggregate), using an expected life of 5 years, volatility of 44%, and a risk-free rate of 5%. However, because the Company’s units did not have a trading history, the volatility assumption was based on information then available to management. The volatility estimate is derived using historical data of public companies in the proposed industry. The Company believes the volatility estimate calculated from these companies is a reasonable benchmark to use in estimating the expected volatility of our units; however, the use of an index to estimate volatility may not necessarily be representative of the volatility of the underlying securities. Although an expected life of five years was used in the calculation, if the Company does not consummate a Business Combination with the prescribed time period and it liquidates the option will become worthless. | |||
The Company has engaged the representative of the underwriters on a non-exclusive basis as an agent for the solicitation of target for a Business Combination. The Company has agreed to pay the representative of the underwriters a transaction fee in cash equal to 3% of the aggregate consideration paid by the Company in a Business Combination with a target business the representative of the underwriters introduces to the Company, if such Business Combination is consummated within twenty-four months of such introduction. | |||
The Company has engaged the representative of the underwriters, on a non-exclusive basis, as its agent for the solicitation of the exercise of the Warrants. To the extent not inconsistent with the guidelines of the Financial Industry Regulatory Authority and the rules and regulations of the Securities and Exchange Commission, the Company has agreed to pay the representative of the underwriter for bona fide services rendered a commission equal to 3% of the exercise price for each Warrant exercised more than one year after the date of the Public Offering prospectus if the exercise was solicited by the representative. In addition to soliciting, either orally or in writing, the exercise of the Warrants the representative’s services may also include disseminating information, either orally or in writing, to Warrant holders about the Company or the market for the Company’s securities, and assisting in the processing of the exercise of the Warrants. No compensation will be paid to the representative upon the exercise of the Warrants if: | |||
|
· |
The
market price of the underlying shares of common stock is lower than
the
exercise price;
|
|
· |
The
holder of the Warrants has not confirmed in writing that the
representative solicited the
exercise;
|
· |
The
Warrants are held in a discretionary account;
|
||
|
· |
The
Warrants are exercised in an unsolicited transaction;
or
|
|
· |
The
representative has not provided to the holder of the Warrants solicited
for exercise a copy of the Public Offering prospectus with respect
to the
shares of common stock underlying the Warrants.
|
||
|
|||
The Company has engaged Selway Partners LLC, an entity with which several of the Company’s officers and directors are affiliated for an aggregate monthly fee of $7,500 for certain administrative, technology, bookkeeping and secretarial services, as well as, the use of limited office space in New Jersey. | |||
On May 1, 2007, the Company entered into a $500,000 revolving credit agreement with SCP Private Equity Management Company, LLC, of which the Company’s Chief Executive officer and one of its directors are members. Any amounts outstanding under the revolving credit agreement will bear interest at a rate of 5.5% per year. Any funds outstanding under the revolving credit agreement will become due and payable by the Company upon our consummation of a business combination. As of June 30, 2008, the Company has not borrowed any amounts under this facility. |
On
February 14, 2008, Vector and its newly-formed, wholly-owned
subsidiary Cyalume Acquisition Corp. (‘‘Transaction Subsidiary’’), entered
into a stock purchase agreement with Cyalume Technologies, Inc.
(‘‘Cyalume’’) and GMS Acquisition Partners Holdings, LLC (‘‘Seller’’),
which owns 100% of the issued and outstanding equity securities of
Cyalume, pursuant to which the Transaction Subsidiary will acquire
all of
the outstanding securities of Cyalume, resulting in Cyalume becoming
an
indirect wholly-owned subsidiary of Vector. The total transaction
consideration will equal $117,196,687 minus $40,621,808 for the repayment
of the indebtedness of Cyalume, Cyalume’s unpaid acquisition expenses, and
the value of the 1,505,646 shares placed in escrow at a contractually
agreed value of $7.97 per share (which was based on the amount per
public
share held in the trust account as of the date of the purchase agreement).
The estimated closing payment will be adjusted based on an estimate
of
Cyalume’s net working capital on the closing date. If Cyalume’s estimated
net working capital is above $9,000,000, then the estimated closing
payment will be increased, on a dollar for dollar basis, by the amount
that the estimated net working capital exceeds $9,000,000. If Cyalume’s
estimated net working capital is below $7,000,000, then the estimated
closing payment will be reduced, on a dollar for dollar basis, by
the
difference between the estimated net working capital and $7,000,000.
A
number of shares held in escrow with a value equal to any adjustment
on
Vector’s behalf will be returned to Vector for cancellation in
satisfaction of such adjustment. The amount held in escrow will be
available for any purchase price adjustment and/or indemnification
obligation of Seller. The
Company has filed preliminary proxy statement on Schedule 14A which
is
pending SEC approval. Once SEC approval is received the Company will
hold
a meeting and the shareholders will vote on the proposed business
combination.
|
9.
Subsequent Event
|
On
July 31 2008, Vector signed a commitment letter for a senior secured
credit facility from TD Banknorth N.A. in the aggregate amount of
$30
million (collectively, the “TD Loan”). The TD Loan is divided into three
distinct facilities, consisting of (i) a $5,000,000 senior secured
revolving credit facility (the “Revolver”); (ii) a $20,000,000 amortizing
senior secured term loan (the “Term Loan”); and (iii) a $5,000,000
commercial real estate mortgage loan (the “CREM”). The TD Loan is to close
on or before November 30, 2008, and the Revolver, Term Loan and CREM
are
to mature three, five and five years from the closing date of the
TD Loan,
respectively. Cyalume would be the borrower under the facilities,
which
would close concurrently with the proposed acquisition of Cyalume
(discussed in further detail in Item 2, below), and the TD Loan is
guaranteed by Vector, Cyalume Technologies, S.A., a wholly-owned
subsidiary of Cyalume, and all existing or future subsidiaries of
Cyalume.
|
|
The
TD Loan, as well as any interest rate hedging provided by TD Banknorth,
will be secured by a first priority perfected security interest in
all of
Cyalume’s tangible and intangible assets and all proceeds thereof. The
Loans will also be secured by a pledge by Vector of Cyalume’s capital
stock, 2/3 of Cyalume Technologies, S.A.’s capital stock, and a first
mortgage on Cyalume’s real estate property located in West Springfield,
MA. Cyalume is to pay an origination fee at closing in an amount
equal to
1% of the TD Facility ($300,000), and Vector will pay a commitment
fee of
$10,000 per month, which is payable whether or not the transaction
closes.
Cyalume will also pay a fee equal to one half of one percent of the
average daily unused portion of the Revolver, payable quarterly in
arrears, after Closing.
|
||
Interest
will accrue and payments will be due monthly in arrears on each of
the
Revolver and Term Loan at a rate determined by adding the applicable
margin to (i) the prime rate as reported in the Wall Street journal
or
(ii) 30, 60, or 90 day LIBOR, at Cyalume’s election so long as no default
has occurred or is continuing. The applicable margin will be set
quarterly
and will be based on a ratio of Cyalume’s senior debt to its adjusted
EBITDA. The initial Prime Rate margin will be 1.5% and the initial
LIBOR
margin will be 3.5%, with a 30 day LIBOR floor of 3.0%. The default-rate
of interest will be 2% above the applicable non-default interest
rate.
Other debts incurred by Cyalume will be subordinate to the TD Loan
and on
terms acceptable to the lender. Cyalume will provide monthly, quarterly
and annual reports to the lender to test Cyalume’s compliance with various
financial covenants under the TD Loan.
|
||
The
terms of the TD Loan are subject to the satisfactory completion of
due
diligence, credit approval, satisfactory review of documentation
and such
other terms and conditions as are determined by TD
Banknorth.
|
ITEM 2 |
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
ITEM 3 |
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
ITEM 4 |
CONTROLS
AND PROCEDURES
|
ITEM 4T |
CONTROLS
AND PROCEDURES
|
ITEM 1 |
LEGAL
PROCEEDINGS
|
ITEM 1A |
RISK
FACTORS
|
ITEM 2 |
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
ITEM 3 |
DEFAULTS
UPON SENIOR SECURITIES
|
ITEM 4 |
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY
HOLDERS
|
ITEM 5 |
OTHER
INFORMATION
|
ITEM 6 |
EXHIBITS
|
Exhibit
No.
|
Description
|
|
31.1
|
Certification
of the Chief Executive Officer (Principal Executive, Accounting and
Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange
Act, as amended.
|
|
32.1
|
Certification
of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
VECTOR INTERSECT SECURITY ACQUISITION CORP.
|
||
|
|
|
Date: August 14, 2008 | By: | /s/ Yaron Eitan |
Yaron
Eitan
|
||
Chief
Executive Officer
(Principal
Executive, Accounting and Financial
officer)
|
Exhibit
No.
|
Description
|
|
31.1
|
Certification
of the Chief Executive Officer (Principal Executive, Accounting and
Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange
Act, as amended.
|
|
32.1
|
Certification
of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|